electroCore, Inc. (NASDAQ:ECOR - Get Free Report) was the target of a large decline in short interest in December. As of December 31st, there was short interest totalling 89,500 shares, a decline of 22.8% from the December 15th total of 115,900 shares. Based on an average trading volume of 124,900 shares, the days-to-cover ratio is currently 0.7 days. Currently, 1.7% of the shares of the stock are short sold.
Wall Street Analyst Weigh In
Separately, HC Wainwright boosted their target price on electroCore from $22.00 to $25.00 and gave the stock a "buy" rating in a research report on Wednesday, December 18th.
View Our Latest Analysis on electroCore
Institutional Trading of electroCore
Several large investors have recently modified their holdings of the business. HighTower Advisors LLC purchased a new stake in electroCore in the 3rd quarter valued at approximately $255,000. Geode Capital Management LLC raised its holdings in shares of electroCore by 10.3% in the third quarter. Geode Capital Management LLC now owns 63,485 shares of the company's stock worth $458,000 after acquiring an additional 5,951 shares during the last quarter. Renaissance Technologies LLC boosted its stake in shares of electroCore by 3.4% during the second quarter. Renaissance Technologies LLC now owns 68,786 shares of the company's stock valued at $442,000 after acquiring an additional 2,270 shares during the last quarter. Finally, International Assets Investment Management LLC boosted its stake in shares of electroCore by 689.1% during the third quarter. International Assets Investment Management LLC now owns 535,146 shares of the company's stock valued at $3,864,000 after acquiring an additional 467,326 shares during the last quarter. 26.74% of the stock is currently owned by institutional investors and hedge funds.
electroCore Stock Performance
NASDAQ ECOR traded up $0.29 during trading hours on Thursday, reaching $15.99. The company's stock had a trading volume of 43,892 shares, compared to its average volume of 89,035. The stock has a market cap of $104.70 million, a PE ratio of -8.73 and a beta of 0.50. The company's 50-day moving average is $13.95 and its two-hundred day moving average is $9.49. electroCore has a fifty-two week low of $5.32 and a fifty-two week high of $18.67.
About electroCore
(
Get Free Report)
electroCore, Inc, a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania.
Recommended Stories
Before you consider electroCore, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and electroCore wasn't on the list.
While electroCore currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.